ENDOMETRIAL ADENOCARCINOMA
Clinical trials for ENDOMETRIAL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ENDOMETRIAL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for ENDOMETRIAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug targets Hard-to-Treat tumors in early trial
Disease control CompletedThis study tested a drug called bemarituzumab in 260 adults with solid tumors that have high levels of a protein called FGFR2b. The main goals were to see if the drug is safe and if it can shrink tumors. Participants had already tried other treatments without success.
Matched conditions: ENDOMETRIAL ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 17, 2026 01:41 UTC
-
Genetic screening of 1,000+ endometrial cancer patients paves way for personalized care
Knowledge-focused CompletedThis study screened over 1,000 women with endometrial cancer for specific DNA changes that can help doctors choose the most effective treatments. It also looked for inherited mutations linked to Lynch syndrome, which increases cancer risk in families. The goal was to improve pers…
Matched conditions: ENDOMETRIAL ADENOCARCINOMA
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jun 17, 2026 01:42 UTC